ATRIUM GRAFT
Report
- Report Number
- 3011175548-2017-00304
- Event Type
- Injury
- Date Received
- November 21, 2017
- Report Date
- November 21, 2017
- Manufacturer
- ATRIUM MEDICAL
- Product Code
- DSY
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
A COMPLETE INVESTIGATION WAS NOT ABLE TO BE PERFORMED AS NO PRODUCT CODE, LOT NUMBER, OR SAMPLE WAS PROVIDED. THE ARTICLE CONCLUDED SIGNIFICANTLY BETTER PATENCY RATES WERE ACHIEVED WITH THE HBD THAN WITH PTFE AT 3 YEARS, BUT THE DIFFERENCE WAS NO LONGER STATISTICALLY SIGNIFICANT AT 5 YEARS. THE INCIDENCE OF MAJOR LIMB AMPUTATION, HOWEVER, WAS SIGNIFICANTLY GREATER IN THE PTFE GROUP COMPARED WITH THE HBD GROUP AT BOTH 3 AND 5 YEARS OF FOLLOW UP.
ARTICLE RECEIVED: DEVINE, C. A. (2004). HEPARIN-BONDED DACRON OR POLYTETRAFLUORETHYLENE FOR FEMOROPOPLITEAL BYPASS: FIVE-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED MULTICENTER CLINICAL TRIAL. JOURNAL OF VASCULAR SURGERY, 40, 924-931. THE PURPOSE OF THIS IS TO COMPARE HEPARIN-BONDED DACRON (HBD) WITH POLYTETRAFLUOROETHYLNE (PTFE) IN A RANDOMIZED MULTICENTER CLINICAL TRIAL. PER THE ARTICLE: ADVERSE EVENTS IN THE PTFE GROUP INCLUDED: HEMATOMA, INFECTION, LYMPHEDEMA, CELLULITIS, HEMORRHAGE, PYREXIA, ANEMIA, CHEST INFECTION, OCCLUSIONS, STENOSIS AND AMPUTATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 829650 | ATRIUM GRAFT | PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER | DSY | ATRIUM MEDICAL |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |